Marshall Wace’s Checkpoint Therapeutics CKPT Stock Holding History

Marshall Wace’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-18,353	Closed	-$74.1K	–	2757
2025 Q1	$74.1K	Buy	18,353 +7,181	+64%	+$23.9K	﹤0.01%	2516
2024 Q4	$35.8K	Sell	11,172 -51,531	-82%	-$175K	﹤0.01%	2499
2024 Q3	$140K	Buy	+62,703	New	+$145K	﹤0.01%	2339
2021 Q4	–	Sell	-12,179	Closed	-$402K	–	3903
2021 Q3	$402K	Sell	12,179 -13,449	-52%	-$398K	﹤0.01%	2502
2021 Q2	$756K	Buy	+25,628	New	+$710K	﹤0.01%	1942

Marshall Wace's CKPT Position: Q2 2025 in Review

Marshall Wace sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 18,353 shares — an estimated $74.1K sold.

Marshall Wace first reported a position in CKPT in Q2 2021 and held it in 5 quarters. The position peaked at $756K in Q2 2021. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Marshall Wace reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Marshall Wace sold 18,353 Checkpoint Therapeutics shares in Q2 2025, an estimated $74.1K.
Marshall Wace first reported a position in Checkpoint Therapeutics in Q2 2021 and held it in 5 quarters.
Marshall Wace's Checkpoint Therapeutics position peaked at $756K in Q2 2021.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.